Published on Saturday June 06, 2020
Smooth Drug Development May 2020 News Release
We were working on the following new projects in May:
• Smooth Drug Development signed several contracts for medical writing
• We signed a contract for organization of phase III clinical trial with INN: Buserelinum
• We are negotiating an agreement for pharmacovigilance activities.
Clinical Department News
• Clinical study report was prepared for erlotinib project.
• Site Selection visits are being performed by our team in COVID-19 trial.
• Close out visits were performed in Lopinavir and Ritonavir project
• Enrollment in flu vaccine study is completed ahead of schedule
Our BD plans to participate in Bio Virtual Partnering conference